Discontinuation of Infliximab in Patients With Ulcerative Colitis is Associated With Increased Risk of Relapse: A Multinational Retrospective Cohort Study
JavaScript is disabled for your browser. Some features of this site may not work without it.
Discontinuation of Infliximab in Patients With Ulcerative Colitis is Associated With Increased Risk of Relapse: A Multinational Retrospective Cohort Study